Checkboxes in Microsoft Excel are a great tool for tracking progress, improving data organization, and adding an extra layer ...

The advantage of Python is that you can apply operations to larger datasets with hundreds, even thousands, of data points ...

New data from telisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic, colorectal, and solid tumors, highlight progress in AbbVie's growing ADC portfolio designed to target ...

Vepdegestrant is an investigational, orally bioavailable PROteolysis TArgeting Chimera (PROTAC) estrogen receptor degrader. Vepdegestrant is being developed as a potential monotherapy for ER+/HER2- ...

Newcastle, UK, 14 October 2025: Iksuda Therapeutics (Iksuda), the developer of class-leading antibody drug conjugates (ADCs), will present new data from its Phase 1 study of IKS014, a human epidermal ...

CBSE has clarified that no corrections in LOC data will be allowed after the deadline. The Central Board of Secondary Education (CBSE) has issued a circular urging schools, parents, and students to ...

BAAR, Switzerland - Novocure (NASDAQ:NVCR), a $1.47 billion medical technology company whose shares have declined over 55% year-to-date, will present research data on its Tumor Treating Fields ...

Kyverna is currently conducting multiple clinical trials with KYV-101, including registrational trials for stiff person syndrome and myasthenia gravis, as well as Phase 1/2 trials for lupus nephritis.

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services. By submitting this information, I agree to the privacy policy and to learn more about ...

AUSTIN, Texas, Oct. 14, 2025 /PRNewswire/ -- Genprex, Inc. (GNPX) ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...